How do you formulate a diaper rash cream with strong barrier protection and good spreadability?

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

• For a US-market diaper rash cream, we start with a water-in-oil (w/o) emulsion base.
• This structure provides the lasting occlusive barrier.
• We then incorporate 15-25% zinc oxide (often micronized for smoothness) as the key protective and soothing agent.
• Spreadability is engineered by balancing the oil phase viscosity with emulsifiers and adding light silicones or esters for glide, without compromising the barrier integrity.
• Lab batches are rigorously tested for texture, pH, and stability under accelerated conditions.
• The final formula must be non-irritating and pass preservative efficacy testing (PET) per USP 51.
• We can support full safety documentation, including a Cosmetic Product Safety Report compliant with MoCRA.
• MOQ typically starts at 5k-10k units, driven by custom tube/bottle tooling and batch size for stability testing.
• Lead time from approved formula to pilot run is 8-10 weeks, allowing for critical pediatric-use claim testing and label review with your legal team.